Case Law Details
In re Nutricia International Private Limited (CAAR Mumbai)
The present application before the Customs Authority for Advance Rulings (CAAR), Mumbai concerns the classification of the product “Nutrison Protein Plus Multifibre.” The applicant sought an advance ruling on whether the product is classifiable under Tariff Item 2202 99 90 as a non-alcoholic beverage under the Customs Tariff Act, 1975.
The applicant, engaged in import, manufacturing, and marketing of nutritional products, proposed to import the product described as a ready-to-use enteral nutritional liquid designed for dietary management of critical care patients or those suffering from disease-related malnutrition. The product is administered through feeding tubes under medical supervision and is not intended for oral or parenteral use. It contains water, carbohydrates, vegetable oils, proteins, dietary fibres, vitamins, and minerals, and is nutritionally complete.
The applicant argued that the product is classifiable under Heading 2202 as a non-alcoholic beverage. It relied on the General Rules for Interpretation (GRI), HSN Explanatory Notes, and international rulings to contend that the product, being a ready-to-use liquid with nutritive value, falls within “other non-alcoholic beverages.” The applicant emphasized that the definition of beverages does not restrict them to products consumed for refreshment, hydration, or enjoyment, and that liquid nutritional products are also classified under Heading 2202 internationally.
Alternatively, the applicant contended that the product may be classified under Heading 3004 as a medicament. It argued that the product is used under medical supervision for dietary management of critically ill patients and supports recovery, thus serving therapeutic purposes. It also relied on dictionary meanings of “therapeutic” and foreign rulings to support its claim that enterally administered nutritional products can qualify as medicaments.
The applicant rejected classification under Heading 2106, arguing that it is a residuary heading applicable only when goods are not covered elsewhere. It maintained that the product is a beverage and not a food preparation, and therefore cannot fall under Heading 2106.
The jurisdictional Commissionerate examined the competing headings—2202 (non-alcoholic beverages), 3004 (medicaments), and 2106 (food preparations not elsewhere specified). It rejected classification under Heading 2202, stating that beverages under this chapter are understood in common parlance as drinks consumed for refreshment, hydration, or enjoyment. The product in question is not marketed or consumed as a drink but is a nutritionally complete enteral feed administered through tubes to patients unable to consume food normally. Therefore, it lacks the essential character of a beverage.
The Department further clarified that being a liquid and non-alcoholic is not sufficient for classification as a beverage. It emphasized that the product replaces normal food intake and is used for clinical nutrition rather than hydration or refreshment. It also distinguished the international rulings cited by the applicant, noting that those products were consumed orally as supplements or hydration drinks, whereas the present product is a complete nutritional formula administered in a clinical setting.
With respect to Heading 3004, the Department held that Chapter Note 1(a) to Chapter 30 excludes foods or beverages such as dietetic or fortified foods unless they are nutritional preparations for intravenous administration. The product, being composed of food ingredients and administered enterally through the gastrointestinal tract, does not qualify as a medicament. It does not contain pharmacologically active substances and does not directly treat or prevent disease. Nutritional support was distinguished from therapeutic or prophylactic treatment.
The Department also rejected the argument equating enteral feeding with intravenous administration, stating that enteral feeding is physiologically equivalent to eating and does not alter the classification of the product as food. It emphasized that the product is marketed and regulated as a food for special medical purposes and not as a pharmaceutical product.
The Department concluded that Heading 2106 is most appropriate, as it covers food preparations not elsewhere specified. It noted that the product is composed of food ingredients, provides nutritional sustenance, and is intended for human consumption, albeit in a clinical context. The heading is broad and includes preparations for direct consumption, and the product satisfies these conditions.
Author Bio
